Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, Ratings ...

Viridian Metals Inc. (TSXV: VRDN) ("Viridian or the "Company") is pleased to announce that it has received the approval of ...

Leerink Partners analyst Thomas Smith has maintained their bullish stance on VRDN stock, giving a Buy rating on January 14.Invest with ...

Australia’s only maker of specialist glass, whose products were used in Canberra’s Parliament House, could not compete with ...

The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Viridian Metals Inc. ("Viridian" or ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Viridian Metals (TSXV: VRDN) announced Friday it has expanded its land position in Canada’s Labrador through staking, securing 2,600 km² of the prospective Seal Basin. This newly acquired ...